HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson ...
RefleXion Medical’s SCINTIX biology-guided radiotherapy platform (BgRT) has shined in an observational study involving lung and bone cancer patients. During the US-based PREMIER trial (NCT05406167), ...
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, Inc., a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality that will one day treat all stages of cancer, ...
Targeted radiotherapy company RefleXion Medical has raised $80 million to help broaden its cancer offerings after recently exploring the company’s potential in treating prostate cancer and other ...
Just over a year after being recognized by the FDA for the potential “breakthrough” nature of its radiation therapy technology, RefleXion Medical has gotten the go-ahead from the agency to begin ...
SAN DIEGO, CA--(Marketwired - March 10, 2016) - Reflexion Health, a digital health and telemedicine company dedicated to bringing personalized healthcare into patients' homes, today announced the ...
RefleXion Medical, an external-beam theranostic oncology company, today announced that two Medicare Administrator Contractors (MACs) have established payment rates for SCINTIX® autonomous radiotherapy ...
RefleXion Medical announces the promotion of Phil Aulson to chief operating officer. The theranostic oncology company develops and commercializes SCINTIX biology-guided radiotherapy, a groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results